NCT01467531
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +17 more
- Locations
-
- GSK Investigational Site Buffalo, New York, United States
Clinical trial condition
Acquired Immunodeficiency Syndrome
Explore clinical trials studying Acquired Immunodeficiency Syndrome. Study availability and eligibility vary by location and protocol.
2,558 public trials
178 recruiting studies
Acquired Immunodeficiency Syndrome trial results
NCT01622790
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Overland Park, Kansas, United States
NCT00405821
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +22 more
- Locations
-
- Rakai Health Sciences Program, Uganda Virus Research Institute Kalisizo, Rakai District, Uganda
NCT01071031
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
- Locations
-
- Grahame Hayton Unit, Ambrose King Centre, Royal London Hospital London, United Kingdom
- St. Stephen's Centre, Chelsea and Westminster Foundation Trust London, United Kingdom
- Elton John Centre, Sussex House, Brighton, United Kingdom
- North Manchester General Hospital, Department for Infectious Diseases Manchester, United Kingdom
NCT00197613
- Conditions
- AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +15 more
- Locations
-
- Princess Marina Hospital Gaborone, Botswana
NCT01683461
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- University of KwaZulu-Natal Durban, South Africa
NCT00144365
- Conditions
- AIDS, Acquired Immunodeficiency Syndrome, Behavior, +16 more
- Locations
-
- The AIDS Support Organization Jinja, Uganda
NCT01656070
- Conditions
- Acquired Immunodeficiency Syndrome, Avitaminosis, Blood-Borne Infections, +24 more
- Locations
-
- Department of Paediatrics - L. Sacco Hospital Milan, Italy
NCT00398125
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site San Diego, California, United States
- GSK Investigational Site San Francisco, California, United States
Completed
Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023
NCT01348516
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- Clinical Trials Center, Seoul National University Hospital Seoul, South Korea